JP Morgan Private Wealth Advisors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-6,500
Closed -$521K – 1398
2016
Q4
$521K Buy
6,500
+2,240
+53% +$178K ﹤0.01% 790
2016
Q3
$340K Sell
4,260
-776
-15% -$62.6K ﹤0.01% 935
2016
Q2
$393K Buy
5,036
+1,078
+27% +$76.9K ﹤0.01% 871
2016
Q1
$218K Sell
3,958
-820
-17% -$44.7K ﹤0.01% 1050
2015
Q4
$295K Buy
4,778
+1,153
+32% +$72.7K ﹤0.01% 868
2015
Q3
$229K Sell
3,625
-4,044
-53% -$289K ﹤0.01% 894
2015
Q2
$560K Buy
7,669
+434
+6% +$31.4K 0.01% 637
2015
Q1
$473K Buy
7,235
+100
+1% +$6.65K 0.01% 742
2014
Q4
$464K Sell
7,135
-393
-5% -$25.3K 0.01% 735
2014
Q3
$454K Buy
7,528
+2,966
+65% +$194K 0.01% 719
2014
Q2
$316K Buy
+4,562
New +$296K 0.01% 703

Other funds holding STJ

JP Morgan Private Wealth Advisors's STJ Position: Q1 2017 in Review

JP Morgan Private Wealth Advisors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,500 shares — an estimated $521K sold.

JP Morgan Private Wealth Advisors first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $560K in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • JP Morgan Private Wealth Advisors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 6,500 St Jude Medical shares in Q1 2017, an estimated $521K.
  • JP Morgan Private Wealth Advisors first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • JP Morgan Private Wealth Advisors's St Jude Medical position peaked at $560K in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2017, filed 15 May 2017.